Text Size
227 studies found for:    treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown † Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
2 Recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
3 Unknown † Once Daily 3TC, Efavirenz and ddI for HIV Infection
Conditions: HIV Infection;   AIDS
Intervention: Drug: once daily minimum 3-drug regimen of anti-retroviral medications
4 Unknown † The Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
Intervention:
5 Unknown † Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression
Condition: HIV Infection
Intervention: Drug: resume raltegravir
6 Unknown † The First Failure Study
Conditions: HIV;   HIV Infections
Interventions: Drug: Darunavir, Ritonavir, Truvada;   Drug: Darunavir, Ritonavir and Etravirine
7 Unknown † A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Conditions: HIV-1;   HIV Infections
Interventions: Other: VircoType HIV-1 genotypic interpretation;   Other: Local Expert Review of HIV Genotypic resistance testing
8 Recruiting Phase 3b Open-Label, Single Arm Study to Evaluate the Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Cobicistat;   Drug: Darunavir
9 Unknown † Raltegravir in the Swiss HIV Cohort Study
Condition: HIV Infection
Intervention: Drug: Raltegravir
10 Unknown † Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
Intervention:
11 Unknown † A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
12 Recruiting Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
13 Unknown † Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia
Conditions: HIV Infection;   Hemophilia A
Intervention:
14 Recruiting GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
Conditions: HIV-1 Infected Patients;   Fold-change Resistance;   Resistance Mutations
Intervention:
15 Recruiting Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
Condition: HIV Infections
Intervention: Drug: Etravirine (ETR)
16 Unknown † Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients
Condition: HIV
Intervention: Drug: raltegravir
17 Recruiting Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
Conditions: HIV;   Lymphoma
Intervention:
18 Recruiting DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
Condition: HIV
Interventions: Drug: Twice-daily Darunavir/ritonavir;   Drug: Once-daily Darunavir/ritonavir
19 Unknown † High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Conditions: HIV;   AIDS
Intervention: Drug: Kaletra (drug)
20 Recruiting EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years